Focused completely on the development of bispecifics, the World Bispecific Summit represents a unique opportunity to engage with your peers to discuss strategies to overcome the key challenges holding back progress in the field.
Rather than presenting vague overviews of platforms, this meeting will delve directly into the technical and scientific insights that will enable you to advance your candidate therapeutic into the clinic as efficiently and cost-effectively as possible.
Full Access Pass: USD 4097.0
Conference Only: USD 2899.0
Pre-Conference Day Only: USD 1398.0
Speakers: Patrick Baeuerle, Managing Director, MPM Capital, Danielle Dettling, Director, R&D, Maverick Therapeutics, Sara Santagostino, Scientist, Pathologist, Safety Assessment, Genentech, Omid Vafa, CBO, TeneoBio, Christian Cimander, Director, CMC, Genmab, Igor D’Angelo, Senior Research Scientist, Molecular Engineering, Amgen, Jon Wigginton, CMO & SVP, Clinical Development, MacroGenics, Alison Betts, Associate Research Fellow, Translational Modeling & Simulation, Pfizer